2021 annual financial data
Aquestive Therapeutics 2021 Operating margin
Direct answer
Operating margin was -68.22%.
Operating income was -34,679,000 USD and net income was -70,539,000 USD.
Operating cash flow was -32,979,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,832,000 USD
- Operating income
- -34,679,000 USD
- Net income
- -70,539,000 USD
- Operating cash flow
- -32,979,000 USD